A low-dose aspirin regimen may represent a new avenue for reducing Alzheimer’s disease pathology, according to new research in a mouse model. The study identifies a new role for one of the most widely used medications in the world.
A low-dose aspirin regimen may represent a new avenue for reducing Alzheimer’s disease pathology, according to new research in a mouse model. The study identifies a new role for one of the most widely used medications in the world.